Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry. Margalida Calafat , Miriam Manosa , Elena Ricart , Pilar Nos , Eva Iglesias-Flores , Isabel Vera , Antonio Lopez-SanRoman , Jordi Guardiola , Carlos Taxonera , Miguel Minguez , M. Dolores Martin-Arranz , Luisa de Castro , Ruth de Francisco , Montserrat Rivero , Esther Garcia-Planella , Xavier Calvet , Santiago Garcia-Lopez , Lucia Marquez , Fernando Gomollon , Jesus Barrio , Maria Esteve , Fernando Munoz , Javier P. Gisbert , Ana Gutierrez , Joaquin Hinojosa , Federico Arguelles-Arias , David Busquets , Luis Bujanda , Jose L. Perez-Calle , Beatriz Sicilia , Olga Merino , Pilar Martinez , Fernando Bermejo , Rufo Lorente , Manuel Barreiro-de Acosta , Cristina Rodriguez , Mariana Fe Garcia-Sepulcre , David Monfort , Fiorella Canete , Eugeni Domenech Journal of Crohn's and colitis（2021）
关键词
Elderly, inflammatory bowel disease, adverse events
AI 理解论文
溯源树
样例
